Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia

By sjmartinez • January 20, 2023

Kanda E, Rastogi A, Murohara T, Lesén E, Agiro A, Arnold M, Chen G, Yajima T, Järbrink K, Pollack CV Jr. Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia. BMC Nephrol. 2023 Jan 19;24(1):18. doi: 10.1186/s12882-022-03054-5. PMID: 36658531.

Tags: Chronic kidney disease, Guideline-directed medical therapy, heart failure, Hyperkalemia, Nephrology, Potassium binder, Publications

A Unique Case of a Mildly Symptomatic Patient With Severe Hypokalemia Secondary to Furosemide

Dao KT, Dhillon A, Uddin SS, Eppanapally S, Lai H. A Unique Case of a Mildly Symptomatic Patient With Severe Hypokalemia Secondary to Furosemide. J[...]

Semaglutide and kidney function: direct kidney protection or an artifact?

Ayoub I, Wong G, Glassock RJ. Semaglutide and kidney function: direct kidney protection or an artifact? Kidney Int. 2024 Nov 18:S0085-2538(24)00793-2. doi: 10.1016/j.kint.2024.11.003. Epub ahead[...]

Association of Fibroblast Growth Factor 23 and Cardiac Mechanics in the Cardiovascular Health Study

Jain K, Katz R, Isakova T, Kizer JR, Sharma S, Psaty BM, Shah S, Ix J, Mehta R. Association of Fibroblast Growth Factor 23 and[...]